Notebookcheck Logo

Dexcom G7 continuous glucose monitor system seemingly nears European launch as the next-gen CGM awaits FDA clearance

The upcoming Dexcom G7 (left) is much smaller than the G6 CGM system (right). (Image source: Dexcom - edited)
The upcoming Dexcom G7 (left) is much smaller than the G6 CGM system (right). (Image source: Dexcom - edited)
The Dexcom G7 continuous glucose monitor (CGM) could finally be close to a European launch. A Google search for the G7 device reveals Dexcom had already prepared a CE Mark-approved landing page for the successor to the G6. Approval in the US from the FDA seems likely after a recent Dexcom G7 clinical study yielded promising results.
Biotech Leaks / Rumors Wearable

Millions of continuous glucose monitor (CGM) users are anxiously awaiting the G7 system from Dexcom. Its G6 CGM system has proved to be very popular, offering discreet glucose monitoring and management around the clock for users with type 1 or type 2 diabetes while also doing away with annoying fingersticks for the most part. The Dexcom G7 promises numerous improvements over its predecessor, including being 60% smaller, delivering a much quicker warm-up time (30 min vs. 120 min for the G6), and combining the transmitter and sensor.

It appeared the COVID-19 pandemic ruined the release schedule for the disposable Dexcom G7 CGM, with its actual launch date being pretty much a mystery. However, it is possible that Dexcom expects the ball to start rolling very soon, as a Google search for the G7 reveals a locked page that had already been created for the monitor. While the current page is blank, the Google search description offers some clues:

Dexcom G7 receives CE Mark – Introducing the Dexcom G7 CGM System…The next-generation Dexcom G7 can make diabetes management powerfully simple with a small, all-in-one wearable sensor and…

The locked web page has been cached by Google, so it can still be seen, with screenshots provided below for those curious about the G7 CGM. The Dexcom G7 was expected to receive the CE Mark required for production and sales in the European Economic Area at the end of 2021, which can be corroborated by the upload date (Dec 21) of the unlisted "forward-looking" statement video that is also embedded below. FDA approval for the Dexcom G7 may come in 2022, although as the company’s CEO Kevin Sayer pointed out in a recent interview, the FDA is unsurprisingly giving priority to COVID-19-related projects at the moment.

The G7 is expected to be a disposable 10-day sensor with potential for extension to 14 days, and it will transmit continuous glucose level measurements to nearby connected smart devices. The recent clinical study showed that Dexcom G7 blood sugar readings were +/- 20% of a confirmed result produced using the fingerstick method for 93% of the time, taken from 300 participants amassing 39,000 readings. Cost is unknown, but the Dexcom G6 costs about US$3,800 a year, so the G7 could be similar. The good news is that Medicare has expanded its insurance coverage in regard to CGM devices.

Buy G6 adhesive patches on Amazon

Dexcom G7. (Image source: Dexcom)
Dexcom G7
Dexcom G7. (Image source: Dexcom)
Dexcom G7
Dexcom G7. (Image source: Dexcom)
Dexcom G7

Related Articles

The FreeStyle Libre 3 continuous glucose monitor is extremely small and can be used for 14 days before replacing. (Image source: Abbott - edited)
FreeStyle Libre 3 gets FDA clearance opening up the US market for the world's smallest and most-accurate 14-day continuous glucose monitor 06/03/2022
The GWave non-invasive blood glucose monitor could help millions of diabetics with disease management. (Image source: HAGAR - edited)
Hagar showcases favorable GWave non-invasive blood glucose monitor data at ATTD following FDA breakthrough device designation 04/28/2022
The GlucoModicum CGM consists of a Talisman sensor, Flint wearable, and MHD technology. (Image source: GlucoModicum - edited)
GlucoModicum needle-free MHD technology for non-invasive glucose monitoring achieves promising precision levels 04/15/2022
The Afon blood glucose (BG) monitor can be used with or without a smartwatch. (Image source: Afon - edited)
Exciting non-invasive blood glucose monitor details promised by Afon for upcoming ATTD Conference 04/09/2022
The BioButton Rechargeable is a stick-on wearable that can monitor over 20 vital signs. (Image source: BioIntelliSense)
BioIntelliSense launches BioButton Rechargeable wearable that can measure over 20 vital signs 04/01/2022
The Afon needle-free CGM can be attached to a smartwatch or wearable monitor that displays BG levels. (Image source: Afon)
Non-invasive Afon blood glucose monitor makes vital accuracy breakthrough 03/31/2022
The Oura Ring now has one million users. (Image source: Oura)
Oura Ring fitness tracker hits one million user milestone and announces upcoming features 03/25/2022
The Dexcom G7 CGM is much smaller than its predecessor, making it ideal for discreet wear. (Image source: Dexcom - edited)
Upcoming Dexcom G7 continuous glucose monitor secures European CE Mark with FDA clearance and Apple Watch compatibility also on the cards 03/16/2022
Innocn 27-inch 4K HDR400 monitor with FreeSync now on sale for $280 USD (Source: Amazon)
Innocn 27-inch 4K monitor with FreeSync is now at its cheapest for just $280 USD 03/16/2022
The D-Pocket non-invasive blood glucose monitor only requires the user to put their finger on the sensor. (Image source: DiaMonTech - edited)
D-Pocket personal non-invasive blood glucose monitor from DiaMonTech attracts substantial investment from Samsung Ventures 03/04/2022
MySugarWatch has licensed the glucose monitor form of the BEAT sensor from Nemaura. (Image source: MySugarWatch - edited)
MySugarWatch needle-free continuous glucose monitor for type 2 diabetes on the cards as award-winning Nemaura posts encouraging financials 03/01/2022
Movano has produced a rendering of its non-invasive continuous glucose monitor wearable. (Image source: Movano - edited)
Wrist-worn non-invasive continuous glucose monitor from Movano takes step closer to FDA clearance after type 1 diabetes pilot study completion 02/24/2022
The GraphWear non-invasive CGM should offer pain-free and needle-free method of diabetes management. (Image source: MedTech Innovator/GraphWear)
Encouraging GraphWear needle-free continuous glucose monitoring wearable project attracts big hitters from Dexcom and Fitbit 02/17/2022
The Eversense CGM system consists of an implantable sensor, a discreet transmitter, and a custom mobile app. (Image source: Senseonics - edited)
FDA approves Eversense E3 6-month continuous glucose monitor that requires fewer fingerstick blood glucose measurements 02/12/2022
The KnowU non-invasive glucose monitor relies on limited-time radio frequency exposure to take measurements. (Image source: Know Labs - edited)
US$200 gift card for KnowU Bio-RFID non-invasive glucose monitoring device study participants as internal clinical trial enrolment opens 02/03/2022
The EYVA non-invasive glucose and healthtech monitor is being manufactured in India. (Image source: EYVA - edited)
EYVA: World's first non-invasive glucose monitor could cost the equivalent of just over US$200 - no blood required but it's not medical grade 01/20/2022
The META Diabet glucoWISE Home Hub system uses radio wave sensors to process blood glucose readings. (Image source: The Imagination Factory)
Diabet non-invasive glucose monitor targets blood draw elimination with the META glucoWISE Home Hub system 01/01/2022
Read all 8 comments / answer
static version load dynamic
Loading Comments
Comment on this article
Please share our article, every link counts!
> Notebook / Laptop Reviews and News > News > News Archive > Newsarchive 2022 03 > Dexcom G7 continuous glucose monitor system seemingly nears European launch as the next-gen CGM awaits FDA clearance
Daniel R Deakin, 2022-03-11 (Update: 2022-03-11)